November 12, 2013: U.S. equity markets opened lower Tuesday morning on another day when no U.S. data of interest was released. Tomorrow looks like another quiet day for U.S. data. Most of the big earnings reports are behind us as well, so there�� not a lot for investors and traders to get excited about.
European and Latin American markets closed lower today while Asian markets closed mixed.
Wednesday�� calendar includes speeches by Fed Chairman Ben Bernanke and Cleveland Fed President Sandra Pianalto and the following scheduled data releases and events (all times Eastern):
7:00 a.m. – Mortgage Bankers Association purchase applications 10:00 a.m. – Atlanta Fed business inflation expectations 11:30 a.m. – 4- and 52-week bill auctions 1:00 p.m. – 10-year note auction 2:00 p.m. – Treasury budgetHere are the closing bell levels for Tuesday:
S&P500 1767.68 (-4.21; -0.24%) DJIA 15750.67 (-32.43; -0.21%) NASDAQ 3919.92 (+0.13; flat) 10YR TNOTE 2.775% (-0.21875) Gold $1,271.20 (-9.90; -0.8%) WTI Crude oil $93.04 (-2.10; -2.2%) Euro/Dollar: 1.3435 (+0.0029; +0.21%)Big Earnings Movers: Hanwha SolarOne Co. (NASDAQ: HSOL) is down 13.9% at $4.36. D.R. Horton Inc. (NYSE: DHI) is up 4.7% at $18.91 on good earnings boosted by land sales.
Top 10 Industrial Conglomerate Companies For 2015: BT Group plc (BT)
BT Group plc provides communications solutions and services worldwide. It engages in the provision of networked IT services; and local, national, and international telecommunications services for use at home, at work, and on the move. The company also offers broadband and Internet products in the United Kingdom (U.K.), as well as TV and converged fixed/mobile services. It operates in four segments: BT Global Services, BT Retail, BT Wholesale, and Openreach. The BT Global Services segment provides managed networked IT services to multinational corporations, domestic businesses, and national and local government organizations. The BT Retail segment offers broadband, telephony, and TV services, as well IT and telephony for small to medium sized businesses in the United Kingdom. It also provides video and telephone conferencing, CCTV, and alarm systems. This segment serves corporate, small and medium enterprises, consumer, and wholesale markets in the U.K., the Republic of Ire land, and Northern Ireland. The BT Wholesale segment provides voice, broadband, and data communications services, including managed services for fixed and mobile network operators, Internet service providers, and telecoms resellers in the U.K. The Openreach segment connects communications providers? customers to their local telephone exchange, giving them access to the U.K. network. The company was formerly known as Newgate Telecommunications Limited and changed its name to BT Group plc in September 2001. BT Group plc was founded in 1981 and is based in London, the United Kingdom.
Advisors' Opinion:- [By Tony Reading]
In this series I'm subjecting companies to scrutiny under five headings: prospects, performance, management, safety, and valuation. How does�BT� (LSE: BT-A ) (NYSE: BT ) measure up?
- [By Mark Rogers]
Today I'm looking at the EPS forecasts for�BT� (LSE: BT-A ) (NYSE: BT ) , the FTSE 100 telecom giant. All my figures are courtesy of S&P Capital IQ.
- [By Alan Oscroft]
BT Group (LSE: BT-A ) (NYSE: BT )
Finally, Friday will see the release of results from BT Group, whose shareholders have enjoyed the biggest share-price appreciation of the three we're looking at today -- at 280 pence, the price is up about 35% over the past 12 months.
Best Asian Companies To Invest In Right Now: Nintendo Co Ltd (NTDOY.PK)
Nintendo Co., Ltd. is a Japan-based company mainly engaged in the leisure machine business. The Company operates in two business segments. The Leisure Machine segment is engaged in the development, manufacturing and sale of portable and console game machines as well as game software. The Others segment is engaged in the manufacture and sale of poker cards and karuta (Japanese-style playing cards), the sale of Pokemon (a Japanese animation character) goods, the management of intellectual property rights and the provision of electronic registration services of home use console machines, among others.
Advisors' Opinion:- [By Philip Saglimbeni]
The good news for Microsoft is that consumers are a fickle bunch and can be swayed rather quickly. The upcoming E3 conference in June is a perfect time for Microsoft to announce a barrage of new games for Xbox One and to provide potential customers with a better understanding of what they can expect at launch for the new system. With Nintendo Co. Ltd. (NTDOY.PK) having backed out of the premiere game conference, it will be Microsoft and Sony facing off directly. In an atmosphere filled with nothing but gamers, big expectations and the potential for even bigger headlines, it won't be much of a competition unless Microsoft chooses to battle Sony in the actual video game department. I expect Microsoft will soon come out swinging with popular blockbuster series announcements but as of right now the console is not effectively convincing the gaming masses and is losing valuable time in its increasingly short release window. Microsoft, you're on notice, put your game face on!
- [By Sneha Shah]
6) Xbox 720 - Microsoft will announce the new version of its blockbuster Xbox game console next month. Its main competitors, Sony (SNE) and Nintendo (NTDOY.PK), have already announced their new game consoles. Xbox has been a tremendous success for Microsoft and has allowed it to gain millions of subscribers for its Xbox LIVE service.
Best Asian Companies To Invest In Right Now: Landec Corporation(LNDC)
Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells polymer products for food and agricultural products, medical devices products, and licensed partner applications incorporating its patented polymer technologies. It has two polymer technology platforms that include Intelimer polymers, a proprietary class of crystalline, hydrophobic polymers, which respond to temperature changes in a controllable, predictable way; and Hyaluronan Biopolymer, a non-crystalline, hydrophilic polymer that exists naturally within the human body. The company?s Food Products Technology segment markets and packs produced and specialty packaged whole and fresh-cut vegetables utilizing the proprietary BreatheWay specialty packaging technology for the retail grocery, club store, and food services industry. This segment also sells BreatheWay packaging to partners for non-vegetable products. Its Food Export segment purchases and sells primarily whole commodity fruit and vegetable products to Asian markets. The company?s Hyaluronan-based Biomaterials segment sells products utilizing hyaluronan, a naturally occurring polysaccharide that is primarily distributed in the extracellar matrix of connective tissues in both animals and humans for medical use primarily in the ophthalmic, orthopedic, and veterinary markets. It also supplies hyaluronan to customers pursuing other medical applications, such as aesthetic surgery, medical device coatings, tissue engineering, and pharmaceuticals. Its Technology Licensing segment licenses Intellicoat, a proprietary seed coating technology to the farming industry; and Intelimer polymers for personal care products and other industrial products. The company sells its products in the United States, Canada, Taiwan, Belgium, Indonesia, China, and Japan. Landec Corporation was founded in 1986 and is based in Menlo Park, California.
Advisors' Opinion:- [By John Kell var popups = dojo.query(".socialByline .popC"); popups.forEach(func]
Landec Corp.(LNDC) said its fiscal third-quarter earnings rose 34% as its food business reported higher revenue.
Lindsay Corp.(LNN) said fiscal second-quarter revenue and earnings fell as the company’s irrigation business remains mired in a sales slump. The company’s results underperformed Wall Street expectations.
- [By Lauren Pollock]
Landec Corp.'s(LNDC) fiscal first-quarter profit grew 8.8% as the food-packaging maker reported higher revenue due to strong demand for vegetables. Margins, however, fell due to an increase in lower-margin food service sales and higher-than-expected raw produce costs.
- [By Laura Brodbeck]
Thursday
Earnings Expected From: Landec Corporation (NASDAQ: LNDC), Resources Connection, Inc. (NASDAQ: RECN) Economic Releases Expected: Indian manufacturing PMI, Spanish manufacturing PMI, Hong Kong retail sales, Italian manufacturing PMI, French manufacturing PMI, German manufacturing PMI, eurozone manufacturing PMI, US manufacturing PMI, Canadian manufacturing PMI, US manufacturing PMIFriday
Best Asian Companies To Invest In Right Now: Pernix Therapeutics Holdings Inc (PTX)
Pernix Therapeutics Holdings, Inc. (Pernix), incorporated in November 8, 1996, is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products for pediatric and adult indications in a range of therapeutic areas. It manages a portfolio of branded and generic products and theobromine, a non-codeine, cough suppressant product candidate in development. The Company�� branded products for the pediatrics market include CEDAX, an antibiotic for middle ear infections, NATROBA, a topical treatment for head lice marketed under an exclusive co-promotion agreement with ParaPRO, LLC and a family of prescription treatments for cough and cold (BROVEX, ALDEX and PEDIATEX). It also markets REZYST IM, which is a probiotic blend to promote dietary management. Pernix markets generic products through its wholly owned subsidiary, Macoven Pharmaceuticals, LLC. In January 2013, the Company acquired Cypress Pharmaceuticals, Inc. and Hawthorn Pharmaceuticals, Inc. In March 2013, the Company acquired Somaxon Pharmaceuticals Inc. In September 2013, Pernix Therapeutics Holdings, Inc. completed the sale of certain non-core assets to Breckenridge Pharmaceutical, Inc.
The Company�� customers consist of drug wholesalers, retail drug stores, mass merchandisers and grocery store pharmacies in the United States. It primarily sells products directly to drug wholesalers, which in turn distribute the products to retail drug stores, mass merchandisers and grocery store pharmacies.
ALDEX Line
ALDEX is a line of antihistamines, decongestants and cough suppressants that are indicated for the temporary relief of respiratory allergies, allergic rhinitis and symptoms of the common cold. The Company�� ALDEX product line is marketed in a range of formulations and combinations using different drug-delivery methodologies to target specific segments of the antihistamine, decongestant and cough suppressant markets. Two used decongestants ar! e phenylephrine and pseudoephedrine.
BROVEX Line
The BROVEX line is a line of antihistamine combinations with the active pharmaceutical ingredient (API) brompheniramine maleate, part of the first generation class of antihistamines called alkylamines that are indicated for the temporary relief of sneezing, itchy, watery eyes, itchy nose or throat, and runny nose due to hay fever or other respiratory allergies. Its BROVEX product line is marketed in a range of formulations and combinations to target specific segments of the antihistamine market. The Company completed the conversion of the BROVEX product family to over-the-counter (OTC) monograph from DESI drugs, in April 2011.
CEDAX Line
CEDAX is a third generation oral cephalosporin indicated for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza or streptococcus pyogenes. The Company sells a range of dosages utilizing both capsule and oral suspension drug delivery methodologies. It also owns a trademark on the name CEDAX in the United States.
NATROBA Line
NATROBA Topical Suspension is a prescription medicine used to treat head lice (pediculosis capitis) in adults and children four years of age and older. NATROBA contains the active ingredient spinosad, which is derived from a naturally occurring soil bacterium.
PEDIATEX Line
As of December 31, 2011, the only product that the Company marketed and sold in its PEDIATEX line is PEDIATEX TD. PEDIATEX TD is an antihistamine/nasal decongestant combination liquid for oral administration. Each 1 milliliter dose contains the API Tripolidine HC1 and Pseudoephedrine HC1. Tripolidine HC1 is a first generation antihistamine in the alkylamine class. Pseudoephedrine, a decongestant, is a sympathomimetic, which acts on alpha-adrenergic receptors in the mucosa of the respiratory tract, producing vasoconstriction and having minimal eff! ect on be! ta-receptors. It therefore functions as an oral nasal decongestant with minimal central nervous system stimulation.
REZYST Line
REZYST IM is a probiotic blend that promotes the dietary management of patients with the distinctive nutritional requirements associated with the gastro-intestinal flora. It is formulated to improve the digestive health of patients by replacing the active cultures altered by diet, stress, and antibiotics.
Product Candidates in Development
Product candidates in development include Theobromine. Theobromine is an alkaloid naturally present in dark chocolate which is an existing human metabolite of caffeine. The Company is working on several other product candidates, which includes a prescription product for the pediatrics market. In March 2012, the Company entered into a product development agreement with a private company for this product.
Advisors' Opinion:- [By Roberto Pedone]
Pernix Therapeutics (PTX), a specialty pharmaceutical company, develops, manufactures, markets and sells branded and generic pharmaceutical products. This stock closed up 5% to $7.53 in Thursday's trading session.
Thursday's Range: $7.11-$7.75
52-Week Range: $1.68-$9.56
Thursday's Volume: 396,000
Three-Month Average Volume: 421,860From a technical perspective, PTX ripped sharply higher here right above some near-term support at $7.10 with decent upside volume. This sharp move to the upside on Thursday is now quickly pushing shares of PTX within range of triggering a near-term breakout trade. That trade will hit if PTX manages to take out some near-term overhead resistance at $8 with high volume.
Traders should now look for long-biased trades in PTX as long as it's trending above some key near-term support levels at $7.10 or at $6.83 and then once it sustains a move or close above $8 with volume that hits near or above 421,860 shares. If that breakout triggers soon, then PTX will set up to re-test or possibly take out its next major overhead resistance levels at $8.93 to $9, or even its 52-week high at $9.56.
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Healthcare stocks gained Wednesday, with Senomyx (NASDAQ: SNMX) leading advancers after the company announced a research agreement with PepsiCo (NYSE: PEP). Among the leading sector stocks, gains came from Pernix Therapeutics Holdings (NASDAQ: PTX), Albany Molecular Research (NASDAQ: AMRI) and Gentiva Health Services (NASDAQ: GTIV). - [By Jake L'Ecuyer]
Leading and Lagging Sectors
Wednesday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Horizon Pharma (NASDAQ: HZNP) and Pernix Therapeutics Holdings (NASDAQ: PTX). In trading on Wednesday, telecommunications services shares were relative laggards, down on the day by about 0.39 percent. Top decliners in the sector included Shenandoah Telecommunications Co (NASDAQ: SHEN), off 3.3 percent, and CalAmp (NASDAQ: CAMP), down around 2.4 percent.
Best Asian Companies To Invest In Right Now: Nektar Therapeutics(NKTR)
Nektar Therapeutics, a clinical-stage biopharmaceutical company, engages in developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms. The company?s product pipeline consists of drug candidates across various therapeutic areas, including oncology, pain, anti-infectives, anti-viral, and immunology. Its research and development activities involve small molecule drugs, peptides, and other potential biologic drug candidates. The company?s proprietary drug candidates in clinical development comprise NKTR-118, a peripheral opioid antagonist, which has completed Phase II clinical trail for the treatment of opioid-induced constipation; BAY41-6551 that has completed Phase II clinical trail to treat gram-negative pneumonias; NKTR-102, a topoisomerase I inhibitor-polymer conjugate, which is in Phase II clinical trail for multiple cancer indications, including breast, ovarian, and colorectal; and NKTR-105 that is in Phase I clinica l trail to treat solid tumors. Its preclinical products consists of NKTR-119 (Opioid/NKTR-118 combinations) for the treatment of pain; NKTR-181 (abuse deterrent, tamper-resistant opioid) to treat pain; NKTR-194 (non-scheduled opioid) for the treatment of mild to moderate pain; NKTR-171 (tricyclic antidepressant) to treat neuropathic pain; and NKTR-140 (protease inhibitor candidate) to treat HIV. The company has collaboration with Bayer Healthcare LLC to develop BAY41-6551 (NKTR-061, Amikacin Inhale), which is an inhaled solution of amikacin, an aminoglycoside antibiotic; and a license agreement with AstraZeneca AB for the development and commercialization of Oral NKTR-118 and NKTR-119. In addition, Nektar Therapeutics has various license, manufacturing, and supply agreements for its technology with biotechnology and pharmaceutical companies, such as Affymax, Amgen, Baxter, Roche, Merck, Pfizer, and UCB Pharma. The company was founded in 1990 and is headquartered in San Franc isco, California.
Advisors' Opinion:- [By Rich Bieglmeier]
Wednesday, June 11, 2014 could be a happy or sad day for event traders who follow the Food and Drug Association's (FDA) calendar. Two biotechs with considerable potential are slated to hear from the regulatory body regarding their applications for approval.
Nektar Therapeutics (NASDAQ:NKTR) Orexigen Therapeutics, Inc. (NASDAQ:OREX)The duo hopes to see �thumbs up from the FDA in a little more than a week. If all things go well, it could be party time for shareholders too.
Best Asian Companies To Invest In Right Now: United Rentals Inc.(URI)
United Rentals, Inc., through its subsidiaries, operates as an equipment rental company. It offers approximately 3,000 classes of equipment for rent to customers comprising construction and industrial companies, manufacturers, utilities, municipalities, homeowners, and government entities. The company?s fleet of rental equipment includes general construction and industrial equipment, such as backhoes, skid-steer loaders, forklifts, earthmoving equipment, and material handling equipment; aerial work platforms consisting of boom lifts and scissor lifts; and general tools and light equipment, including pressure washers, water pumps, generators, heaters, and power tools. Its fleet also comprise trench safety equipment, such as trench shields, aluminum hydraulic shoring systems, slide rails, crossing plates, construction lasers, and line testing equipment for underground work; and power and heating, ventilating, and air conditioning (HVAC) equipment, which consists of portable diesel generators, electrical distribution equipment, and temperature control equipment, including heating and cooling equipment. In addition, the company sells new and used equipment, as well as related contractor supplies, parts, and service; and offers repair, maintenance, and rental protection services. Further, it develops and markets RENTALMAN, an enterprise resource planning application for equipment rental companies; and INFOMANAGER, which offers solution for creating a business intelligence system. As of January 1, 2012, the company had an integrated network of 529 rental locations in the United States and Canada. United Rentals, Inc. was founded in 1997 and is headquartered in Greenwich, Connecticut.
Advisors' Opinion:- [By Ben Levisohn]
Going through his papers, he found a list of stocks that UBS said to buy if Obama won the election in 2012, including the likes of United Rentals (URI) , First Solar (FSLR),�Alliant Techsystems (ATK), Alkermes (ALKS) and Mohawk Industries (MHK). And wouldn’t you know it, those stocks have gained 58% this year, compared to the S&P 500′s 27% gain. And just in case you’re wondering, those stocks have also trumped UBS’s Romney basket, which has gained 33%.
- [By Peter Graham]
The Q2 2014 earnings report for equipment rental stock United Rentals, Inc (NYSE: URI), a peer or competitor of Essex Rental Corp (NASDAQ: ESSX) and H&E Equipment Services, Inc (NASDAQ: HEES), is scheduled for after the market closes on Wednesday. Aside from the United Rentals earnings report, it should be said that the Essex Rental Corp reported Q4 2013 earnings on May 7th while the estimated release date for the H&E Equipment Services, Inc Q2 2014 earnings report is August 4th. However, United Rentals��shares rose after its last earnings report plus analysts have issued bullish research notes since then.
- [By Heather Long]
Some of the stocks he likes now include: Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Actavis (ACT), and United Rentals (URI). All of these are up more than 20% this year with Illumina up over 50%.
- [By BLOGS.BARRONS.COM]
In an earnings report on Wednesday, equipment rental outfit United Rentals (URI) forecast improvement in commercial construction and said the company plans to spend more on equipment. Oshkosh (OSK) will benefit as rental companies increase the size of their construction fleets. Wordell adds that as state and local budgets improve, municipalities will start updating their work fleets with new garbage trucks, fire engines and other vehicles. At a recent $43.42, the stock is trading at just seven times EBITDA.
Best Asian Companies To Invest In Right Now: Network Exploration Ltd (NET)
Network Exploration Ltd. is an exploration and development-stage company. The Company�� principal business activities include the exploration of minerals in its mineral properties. It focuses on base and precious metal properties in North and South America. Its activities include the process of exploring its mineral properties, reviewing and subsequently acquiring mineral properties and conducting exploration programs to determine whether these properties contain ore reserves that are recoverable. The Picha copper-silver project is located within the Tertiary Volcanic Arc of Southern Peru. The Pistala project is located east of the NW-SE trending Incapquio fault system in the Department of Tacna, Southern Peru. The Company is in the business of mineral exploration in Canada, Chile and Peru. Network Exploration Chile Limitada is its wholly owned subsidiary. Advisors' Opinion:- [By Holly LaFon]
The MSCI World Index (Net) is a free float-adjusted market capitalization weighted index that is designed to measure the global equity market performance of developed markets. This benchmark calculates reinvested dividends net of withholding taxes using Luxembourg tax rates. This index is unmanaged and investors cannot invest directly in this index.
- [By Damian Illia]
Although the company is overly relying on Afrezza, there is to say that MannKind has inked some deals in the recent past. These were primarily aimed to furthering its pipeline development but with less risk and with less research and development expenditure directly for the firm. In November, 2012 it signed a license agreement with Colby Pharmaceutical Company granting the latter exclusive rights to its early stage cancer program. Currently, the firm is also looking for partners regarding Afrezza. Last year in July, it entered one with Deerfield that ensured financing worth $160 million for MannKind. Also, in October 2012, the company raised $86 million (net) through the issuance of shares and has almost $120 million left under its credit facility. This has removed some concerned about a financial crisis in the company, although it hasn't done so throughly.
- [By Holly LaFon]
MSCI All Country World Index (Net) is an unmanaged index comprised of 44 country indices comprising 23 developed and 21 emerging market country indices and is calculated with dividends reinvested after de duction of withholding tax. The Index is a trademark of Morgan Stanley Capital International and is not available for direct investment.
No comments:
Post a Comment